Urinary tract infections: what's new?

JN Krieger - The journal of urology, 2002 - auajournals.org
Purpose: This review provides practicing urologists with important basic information about
urinary tract infections (UTIs) that can be applied to everyday clinical problems. Materials …

Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections

C Carson, KG Naber - Drugs, 2004 - Springer
Serious urinary tract infections (UTIs) in adults—defined as acute complicated UTIs or
pyelonephritis requiring initial intravenous antimicrobials and/or hospitalisation and …

Complicated urinary tract infection in adults

LE Nicolle - Canadian Journal of Infectious Diseases and Medical …, 2005 - hindawi.com
BACKGROUND: Complicated urinary tract infection occurs in individuals with functional or
structural abnormalities of the genitourinary tract. OBJECTIVE: To review current knowledge …

Current challenges in the treatment of complicated urinary tract infections and prostatitis

FME Wagenlehner, KG Naber - Clinical Microbiology and …, 2006 - Wiley Online Library
Serious urinary tract infections (UTIs) and acute bacterial prostatitis in adults cause
significant morbidity and economic burden. Chronic bacterial prostatitis is a rather rare …

Explorative randomized phase II clinical study of the efficacy and safety of finafloxacin versus ciprofloxacin for treatment of complicated urinary tract infections

F Wagenlehner, M Nowicki, C Bentley… - Antimicrobial agents …, 2018 - Am Soc Microbiol
ABSTRACT The broad-spectrum C-8-cyano-fluoroquinolone finafloxacin displays enhanced
activity under acidic conditions. This phase II clinical study compared the efficacies and …

Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis

FME Wagenlehner, W Weidner, KG Naber - Clinical pharmacokinetics, 2007 - Springer
Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a
community-acquired or nosocomial urinary tract infection (UTI). Nevertheless, the underlying …

Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose

FME Wagenlehner, M Kinzig-Schippers… - International journal of …, 2006 - Elsevier
The new extended-release formulation of ciprofloxacin (ciprofloxacin XR) was designed for
once-daily administration in the treatment of urinary tract infection (UTI). The aim of this study …

Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis

V Magri, A Trinchieri, G Pozzi, A Restelli… - International journal of …, 2007 - Elsevier
A total of 137 patients with a diagnosis of chronic bacterial prostatitis (CBP) were subjected
to combination pharmacological therapy with antibacterial agents (ciprofloxacin …

Sustained prevention of biofilm formation on a novel silicone matrix suitable for medical devices

SL Steffensen, MH Vestergaard, M Groenning… - European Journal of …, 2015 - Elsevier
Bacterial colonization and biofilm formation on medical devices constitute major challenges
in clinical long-term use of eg catheters due to the risk of (re) infection of patients, which …

[PDF][PDF] Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome

V Magri, A Trinchieri, I Ceriani, E Marras… - ARCHIVIO ITALIANO DI …, 2007 - Citeseer
We performed a comparative analysis of microbiological and clinical responses to
combination therapy in 104 symptomatic patients showing evidence of infection by …